Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Oct;11(10):e1488-e1489.
doi: 10.1016/S2214-109X(23)00407-2.

The place of polypill in secondary prevention of stroke

Dike B Ojji  1 , Mark D Huffman  2
Affiliations
Comment

The place of polypill in secondary prevention of stroke

Dike B Ojji et al. Lancet Glob Health. 2023 Oct.
No abstract available

PubMed Disclaimer

Conflict of interest statement

MDH has received travel support from the American Heart Association and World Heart Federation and holds an appointment at The George Institute for Global Health, which has a patent, license, and has received investment funding with intent to commercialise, fixed-dose combination therapy through its social enterprise business, George Medicines. MDH has pending patents for heart failure polypills. DBO declares no competing interests.

Comment on

References

    1. Zhu JZ, Manne-Goehler J, Agarwal A, et al. Medication use for cardiovascular disease prevention in 40 low- and middle-income countries. J Am Coll Cardiol 2023; 81: 620–22. - PMC - PubMed
    1. WHO. Secondary prevention of noncommunicable diseases in low- and middle-income countries through community based and health service interventions: World Health Organization Wellcome Trust meeting report, 1–3 August 2001. August 2001. https://apps.who.int/iris/handle/10665/42567 (accessed July 28, 2023).
    1. Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80%. BMJ 2003; 326: 1419. - PMC - PubMed
    1. WHO. WHO Model List of Essential Medicines–23rd list, 2023. Jul 26, 2023. https://www.who.int/publications/i/item/WHO-MHP-HPS-EML-2023.02 (accessed Aug 28, 2023).
    1. Sarfo FS, Voeks J, Adamu S, et al. A cardiovascular polypill for secondary stroke prevention in a tertiary centre in Ghana (SMAART): a phase 2 randomised clinical trial. Lancet Global Health 2023; 11: e1619–28. - PMC - PubMed